Alterity Therapeutics CEO David Stamler to Present at the SHARE Series Monday Management Update on Monday, May 22, 2023

ATHE Stock  USD 4.08  0.11  2.63%   
About 55% of Alterity Therapeutics' investor base is interested to short. The analysis of the overall investor sentiment regarding Alterity Therapeutics suggests that many traders are impartial. The current market sentiment, together with Alterity Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Alterity Therapeutics stock news signals to limit their universe of possible portfolio assets.
  
MELBOURNE, Australia and SAN FRANCISCO, May 19, 2023 Alterity Therapeutics, a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today

Read at benzinga.com
benzinga news
  

Alterity Therapeutics Fundamental Analysis

We analyze Alterity Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Alterity Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Alterity Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Cash Per Share

Cash Per Share Comparative Analysis

Alterity Therapeutics is currently under evaluation in cash per share category among its peers. Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.

Alterity Therapeutics Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Alterity Therapeutics stock to make a market-neutral strategy. Peer analysis of Alterity Therapeutics could also be used in its relative valuation, which is a method of valuing Alterity Therapeutics by comparing valuation metrics with similar companies.

Peers

Alterity Therapeutics Related Equities

NBYNovaBay Pharmaceuticals   4.76   
0%
29.0%
PMVPPmv Pharmaceuticals   1.42   
0%
8.0%
SRZNSurrozen   1.25   
0%
7.0%
ANTXAN2 Therapeutics   0.88   
0%
5.0%
ANEBAnebulo Pharmaceuticals   0.79   
4.0%
0%
ADILAdial Pharmaceuticals   2.53   
15.0%
0%
QNRXQuoin Pharmaceuticals   3.13   
19.0%
0%
ARTLArtelo Biosciences   3.33   
20.0%
0%
TARAProtara Therapeutics   4.03   
25.0%
0%
ATXIAvenue Therapeutics   4.41   
27.0%
0%
HCWBHCW Biologics   5.13   
32.0%
0%
RVPHReviva Pharmaceuticals   7.01   
43.0%
0%
MNPRMonopar Therapeutics   10.58   
66.0%
0%
RNAZTranscode Therapeutics   15.99   
100.0%
0%

Complementary Tools for Alterity Stock analysis

When running Alterity Therapeutics' price analysis, check to measure Alterity Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alterity Therapeutics is operating at the current time. Most of Alterity Therapeutics' value examination focuses on studying past and present price action to predict the probability of Alterity Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alterity Therapeutics' price. Additionally, you may evaluate how the addition of Alterity Therapeutics to your portfolios can decrease your overall portfolio volatility.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules